康芝药业
(300086)
| 流通市值：38.52亿 | | | 总市值：39.78亿 |
| 流通股本：4.41亿 | | | 总股本：4.55亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 17,952,248.56 | 47,457,968.17 | 92,968,241.64 | 113,185,485.94 |
| 应收票据及应收账款 | 50,002,232.5 | 61,240,622.77 | 62,276,462.27 | 69,064,843.95 |
| 其中：应收票据 | 3,105,773 | 6,270,000 | 7,053,112.06 | 620,027.75 |
| 应收账款 | 46,896,459.5 | 54,970,622.77 | 55,223,350.21 | 68,444,816.2 |
| 预付款项 | 42,990,620.12 | 28,798,257.08 | 35,390,195.23 | 23,812,161.44 |
| 其他应收款合计 | 28,265,040.42 | 27,868,385.77 | 68,863,963.39 | 42,210,422.6 |
| 存货 | 166,890,605.3 | 167,845,478 | 175,431,076.57 | 187,328,641.2 |
| 其他流动资产 | 4,455,811.63 | 3,381,547.37 | 5,332,695.84 | 7,473,280.71 |
| 流动资产合计 | 310,556,558.53 | 336,592,259.16 | 440,262,634.94 | 443,074,835.84 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 4,973,239.88 | 4,973,239.88 | 4,973,239.88 | 4,973,239.88 |
| 投资性房地产 | 564,864,039.8 | 243,084,839.8 | 243,084,839.8 | 206,272,603 |
| 固定资产 | 686,665,916.96 | 969,802,540.87 | 984,107,132.1 | 992,215,091.57 |
| 在建工程 | 18,500,224.44 | 15,462,518.85 | 14,111,176.62 | 12,034,555.32 |
| 生产性生物资产 | - | - | 17,182.35 | - |
| 使用权资产 | 17,388,659.5 | 17,630,168.65 | 17,871,677.8 | 18,113,187.25 |
| 无形资产 | 101,847,538.5 | 145,830,772.76 | 147,696,426.45 | 139,858,258.34 |
| 开发支出 | 55,600,814.49 | 53,541,380.52 | 50,965,908.82 | 50,965,908.82 |
| 商誉 | 13,500,000 | 13,500,000 | 13,500,000 | 13,500,000 |
| 长期待摊费用 | 26,318,261.85 | 28,540,741.01 | 30,865,756.35 | 26,900,856.85 |
| 递延所得税资产 | 64,217,619.5 | 56,033,371.55 | 50,283,550.67 | 50,648,748.85 |
| 其他非流动资产 | 14,344,385.59 | 19,821,659.12 | 15,141,805 | 17,293,263.97 |
| 非流动资产合计 | 1,568,220,700.51 | 1,568,221,233.01 | 1,572,618,695.84 | 1,532,775,713.85 |
| 资产总计 | 1,878,777,259.04 | 1,904,813,492.17 | 2,012,881,330.78 | 1,975,850,549.69 |
| 流动负债: | | | | |
| 短期借款 | 166,569,336.55 | 124,799,882.1 | 161,341,038.05 | 171,084,544.81 |
| 应付票据及应付账款 | 52,819,801.01 | 49,502,465.12 | 51,249,918.4 | 66,256,942.02 |
| 应付账款 | 52,819,801.01 | 49,502,465.12 | 51,249,918.4 | 66,256,942.02 |
| 预收款项 | 394,346 | 731,063.65 | 240,000 | 485,928.44 |
| 合同负债 | 16,730,600.59 | 36,347,243.25 | 30,048,893.15 | 42,209,406.92 |
| 应付职工薪酬 | 7,604,136.68 | 7,730,244.97 | 7,919,242.48 | 11,180,823.52 |
| 应交税费 | 13,683,454.51 | 10,684,244.15 | 8,628,112.64 | 11,415,974.24 |
| 其他应付款合计 | 134,325,708.35 | 129,725,026.87 | 142,357,298.34 | 76,596,646.73 |
| 一年内到期的非流动负债 | 67,446,610.84 | 88,446,610.84 | 108,876,610.84 | 110,969,527.93 |
| 其他流动负债 | 2,174,978.07 | 4,721,457.43 | 3,903,647.3 | 5,480,752.85 |
| 流动负债合计 | 461,748,972.6 | 452,688,238.38 | 514,564,761.2 | 495,680,547.46 |
| 非流动负债: | | | | |
| 长期借款 | 233,065,000 | 233,065,000 | 239,039,265.69 | 210,000,000 |
| 租赁负债 | 19,194,513.15 | 19,012,665.87 | 18,830,818.59 | 18,648,971.31 |
| 递延收益 | 54,642,909.44 | 55,394,434.07 | 50,870,287.24 | 51,625,213.59 |
| 递延所得税负债 | 36,532,587.43 | 34,456,113.55 | 34,516,490.84 | 34,576,868.2 |
| 非流动负债合计 | 343,435,010.02 | 341,928,213.49 | 343,256,862.36 | 314,851,053.1 |
| 负债合计 | 805,183,982.62 | 794,616,451.87 | 857,821,623.56 | 810,531,600.56 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 455,124,411 | 455,124,411 | 455,124,411 | 455,124,411 |
| 资本公积 | 842,991,008.41 | 842,991,008.41 | 842,991,008.41 | 842,991,008.41 |
| 其他综合收益 | 58,130,740.62 | 51,719,218.63 | 51,729,678.49 | 51,732,777.71 |
| 盈余公积 | 54,941,795.33 | 54,941,795.33 | 54,941,795.33 | 54,941,795.33 |
| 未分配利润 | -361,479,075.88 | -318,949,298.8 | -274,559,275.7 | -264,867,579.44 |
| 归属于母公司股东权益合计 | 1,049,708,879.48 | 1,085,827,134.57 | 1,130,227,617.53 | 1,139,922,413.01 |
| 少数股东权益 | 23,884,396.94 | 24,369,905.73 | 24,832,089.69 | 25,396,536.12 |
| 股东权益合计 | 1,073,593,276.42 | 1,110,197,040.3 | 1,155,059,707.22 | 1,165,318,949.13 |
| 负债和股东权益合计 | 1,878,777,259.04 | 1,904,813,492.17 | 2,012,881,330.78 | 1,975,850,549.69 |
| 公告日期 | 2025-10-27 | 2025-08-28 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |